These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 29311404)

  • 1. Recreational Drug and Psychosocial Profile in Chronic Hepatitis C Patients Seeking Antiviral Therapy.
    George N; Harrell SM; Rhodes KD; Duarte-Rojo A
    Ann Hepatol; 2018; 17(1):76-84. PubMed ID: 29311404
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Time to rethink antiviral treatment for hepatitis C in patients with coexisting mental health/substance abuse issues.
    Bonner JE; Barritt AS; Fried MW; Evon DM
    Dig Dis Sci; 2012 Jun; 57(6):1469-74. PubMed ID: 22484494
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hepatitis C testing and treatment among active drug users in Amsterdam: results from the DUTCH-C project.
    Lindenburg CE; Lambers FA; Urbanus AT; Schinkel J; Jansen PL; Krol A; Casteelen G; van Santen G; van den Berg CH; Coutinho RA; Prins M; Weegink CJ
    Eur J Gastroenterol Hepatol; 2011 Jan; 23(1):23-31. PubMed ID: 21042221
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antiviral regimen complexity index as an independent predictor of sustained virologic response in patients with chronic hepatitis C.
    Galán RJ; Cidoncha EC; Martin MF; Rodriguez CC; Almeida CV; Verdugo RM
    J Manag Care Pharm; 2013; 19(6):448-53. PubMed ID: 23806058
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Older adults who use or have used marijuana: Help-seeking for marijuana and other substance use problems.
    Choi NG; DiNitto DM; Marti CN
    J Subst Abuse Treat; 2017 Jun; 77():185-192. PubMed ID: 28216197
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Psychiatric and substance use disorders in individuals with hepatitis C: epidemiology and management.
    Loftis JM; Matthews AM; Hauser P
    Drugs; 2006; 66(2):155-74. PubMed ID: 16451091
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Psychosocial factors are the most common contraindications for antiviral therapy at initial evaluation in veterans with chronic hepatitis C.
    Rowan PJ; Tabasi S; Abdul-Latif M; Kunik ME; El-Serag HB
    J Clin Gastroenterol; 2004 Jul; 38(6):530-4. PubMed ID: 15220690
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Obstacles to successful HCV treatment in substance addicted patients.
    Cooper CL
    J Addict Dis; 2008; 27(2):61-8. PubMed ID: 18681192
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A novel program for treating patients with trimorbidity: hepatitis C, serious mental illness, and active substance use.
    Sockalingam S; Blank D; Banga CA; Mason K; Dodd Z; Powis J
    Eur J Gastroenterol Hepatol; 2013 Dec; 25(12):1377-84. PubMed ID: 23680911
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Risk of nonpsychotic mental disorders development in antiviral-treated mentally healthy chronic hepatitis C patients: A population-based study.
    Chang SC; Hung CT; Li SF; Lee HM; Chung YC; Pai LW; Yang SS
    J Formos Med Assoc; 2015 Sep; 114(9):829-34. PubMed ID: 24090634
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Co-morbid medical and psychiatric illness and substance abuse in HCV-infected and uninfected veterans.
    Butt AA; Khan UA; McGinnis KA; Skanderson M; Kent Kwoh C
    J Viral Hepat; 2007 Dec; 14(12):890-6. PubMed ID: 18070293
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Increasing antiviral treatment through integrated hepatitis C care: a randomized multicenter trial.
    Groessl EJ; Sklar M; Cheung RC; Bräu N; Ho SB
    Contemp Clin Trials; 2013 Jul; 35(2):97-107. PubMed ID: 23669414
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Psychiatric and substance use disorders among methadone maintenance patients with chronic hepatitis C infection: effects on eligibility for hepatitis C treatment.
    Batki SL; Canfield KM; Ploutz-Snyder R
    Am J Addict; 2011; 20(4):312-8. PubMed ID: 21679262
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Tangible resources for preparing patients for antiviral therapy for chronic hepatitis C.
    Bonner JE; Barritt AS; Fried MW; Evon DM
    Dig Dis Sci; 2012 Jun; 57(6):1439-44. PubMed ID: 22488633
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A randomized controlled trial of an integrated care intervention to increase eligibility for chronic hepatitis C treatment.
    Evon DM; Simpson K; Kixmiller S; Galanko J; Dougherty K; Golin C; Fried MW
    Am J Gastroenterol; 2011 Oct; 106(10):1777-86. PubMed ID: 21769136
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Increase of drug use and genotype 3 in HCV-infected patients from Central West and Northeast Mexico.
    Muñoz-Espinosa LE; Trujillo-Trujillo ME; Martínez-Macías RF; Panduro A; Rivas-Estilla AM; Fierro NA; Silvera-Linares AL; Torres-Valadez R; Cordero-Pérez P; González-Aldaco K; Chen-López CY; José-Abrego A; Zuñiga-Noriega JR; Gutiérrez-Ruiz MC; Roman S
    Ann Hepatol; 2015; 14(5):642-51. PubMed ID: 26256892
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Gaps in the hepatitis C continuum of care among sex workers in Vancouver, British Columbia: Implications for voluntary hepatitis C virus testing, treatment and care.
    Socías ME; Shannon K; Montaner JS; Guillemi S; Dobrer S; Nguyen P; Goldenberg S; Deering K
    Can J Gastroenterol Hepatol; 2015; 29(8):411-6. PubMed ID: 26492129
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Continued Substance Use Among People Living With HIV-Hepatitis-C Co-Infection and Receiving Antiretroviral Therapy.
    Kalichman SC; Washington C; Kegler C; Grebler T; Kalichman MO; Cherry C; Eaton L
    Subst Use Misuse; 2015; 50(12):1536-43. PubMed ID: 26583598
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Identifying Barriers to the Treatment of Chronic Hepatitis C Infection.
    Al-Khazraji A; Patel I; Saleh M; Ashraf A; Lieber J; Malik R
    Dig Dis; 2020; 38(1):46-52. PubMed ID: 31422405
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prevalence and clinical significance of GB virus type C/hepatitis G virus coinfection in patients with chronic hepatitis C undergoing antiviral therapy.
    Hofer H; Aydin I; Neumueller-Guber S; Mueller C; Scherzer TM; Staufer K; Steindl-Munda P; Wrba F; Ferenci P
    J Viral Hepat; 2011 Jul; 18(7):513-7. PubMed ID: 20565572
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.